✨ Free AI Report
Psyence Biomedical Ltd.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview Psyence Biomedical Ltd.
Research Preview

Psyence Biomedical Ltd.: Business Overview, Financials & Competitive Analysis

Psyence Biomedical is a multi-asset, vertically integrated biopharmaceutical company and the first Nasdaq-listed life sciences biotech focused on developing nature-derived psilocybin and ibogaine-based psychedelic med...

Analyst-debate audio for Psyence Biomedical Ltd.

AskCyborg analysts argue the bull and bear cases for Psyence Biomedical Ltd. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Psyence Biomedical Ltd. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
4/ 10Mixed

Cyborg Score thesis

Early-stage psychedelic biotech with solid balance sheet and regulatory tailwinds, but facing execution risk, minimal scale, and...

Read the full analyst-debate transcript →
Industry Biopharmaceuticals - Psychedelic Therapeutics
3 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: July 6, 2026
AI-Verified Research
30+ Page Report

Get the Latest Psyence Biomedical Ltd. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Psyence Biomedical Ltd. Overview

Pro stress-test →

Psyence Biomedical is a multi-asset, vertically integrated biopharmaceutical company and the first Nasdaq-listed life sciences biotech focused on developing nature-derived psilocybin and ibogaine-based psychedelic medicine. The company is dedicated to addressing unmet mental health needs.

Strategic Profile

Pro stress-test →

The company has built a vertically integrated, GMP-compliant pharmaceutical platform through a strategic investment in PsyLabs. Psyence expanded its Australian clinical site network from three to five sites in April 2026, supporting multi-site Phase IIb trials of pharmaceutical-grade psilocybin for Adjustment Disorder in palliative oncology.

Competitive Landscape

Pro stress-test →

Psyence competes in the nascent clinical-stage psychedelic therapeutics space alongside other private and public developers of psilocybin and ketamine therapies. The company's vertically integrated model (clinical development + GMP manufacturing through PsyLabs) differentiates it from pure-play biotech competitors, but the small market cap and limited resources constrain competitive reach against better-capitalized biotech firms pursuing similar indications.

Industry Context

Psyence Biomedical Ltd. operates in Biopharmaceuticals - Psychedelic Therapeutics.

Key facts

Founded: 2024 · Headquarters: New York, US · Employees: 12 · Market cap: $15.3M

What the analysts stress-tested

The top findings that survived the multi-agent debate for Psyence Biomedical Ltd..

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Psyence Biomedical Ltd. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

COMPASS PathwaysCOMPASS Therapeutics: Psilocybin-based therapies for treatment-resistant depression→Tryp TherapeuticsPsilocybin development for mental health disorders→KetamineFDA-approved ketamine nasal spray (Spravato) for depression→

Compare Psyence Biomedical Ltd. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Psyence Biomedical Ltd. operates in Biopharmaceuticals - Psychedelic Therapeutics. See how the rest of the sector scores on the Cyborg framework.

Browse Biopharmaceuticals - Psychedelic Therapeutics research →
NEW · MCP server

Ask your AI assistant about Psyence Biomedical Ltd.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Psyence Biomedical Ltd. and its top competitor on Cyborg Score”
“What did Psyence Biomedical Ltd. do this quarter?”
“Is Psyence Biomedical Ltd. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Psyence Biomedical Ltd. do?+
Psyence Biomedical is a multi-asset, vertically integrated biopharmaceutical company and the first Nasdaq-listed life sciences biotech focused on developing nature-derived psilocybin and ibogaine-based psychedelic med...
What is Psyence Biomedical Ltd.'s Cyborg Score?+
Psyence Biomedical Ltd. has a Cyborg Score of 4/10 (Mixed). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Psyence Biomedical Ltd.'s main competitors?+
Named competitors include COMPASS Pathways, Tryp Therapeutics, Ketamine. The full competitive landscape is in the AskCyborg report.
How can I get the full Psyence Biomedical Ltd. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Psyence Biomedical Ltd. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Psyence Biomedical Ltd. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

Other strong performers across the analyst-debate framework. Click any to see their research report.

9National Bank of Pakistan9RENK Group AG9Lumentum Holdings Inc.9First Abu Dhabi Bank9The Travelers Companies, Inc.9BAE Systems plc9Arista Networks9KLA Corporation9Hermès International S.A.8Enerjisa Enerji A.Ş.8Emirates Central Cooling Systems Corporation8WALLIX Group8StealthGas Inc.8SofWave Medical Ltd.8Himalaya Shipping Ltd.8Bannerman Energy Ltd8Sembcorp Salalah Power & Water Company8MilDef Group